logo
Clinical outcomes trials and the cardiovascular effects of thiazolidinediones
The coin toss
Leveraging observational registries to inform comparative effectiveness research
Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction
The EVEREST II Trial
The Strategic Reperfusion Early After Myocardial Infarction (STREAM) study
Cryptogenic Stroke and underlying Atrial Fibrillation (CRYSTAL AF)
The MOnitoring Resynchronization dEvices and CARdiac patiEnts (MORE-CARE) study
The BioImage Study
Cell-based therapy for myocardial repair in patients with acute myocardial infarction
Rationale and design of the randomized, double-blind trial testing INtraveNous and Oral administration of elinogrel, a selective and reversible P2Y12-receptor inhibitor, versus clopidogrel to eVAluate Tolerability and Efficacy in nonurgent Percutaneous Coronary Interventions patients (INNOVATE-PCI)
Left ventricular function in acute myocardial infarction treated with thrombolysis followed by early versus late invasive strategy
Gender differences in time to presentation for myocardial infarction before and after a national women's cardiovascular awareness campaign
Improving long-term risk prediction in patients with acute chest pain
Chronic obstructive pulmonary disease after myocardial infarction in the community
The impact of combined health factors on cardiovascular disease mortality
Validity of the LaFarge equation for estimation of oxygen consumption in ventilated children with congenital heart disease younger than 3 years—A revisit
Beyond insurance coverage
Cost-effectiveness of implantable cardioverter defibrillators in patients ≥65 years of age
Associations between worsening renal function and 30-day outcomes among Medicare beneficiaries hospitalized with heart failure
Hospice, opiates, and acute care service use among the elderly before death from heart failure or cancer
Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
Race/ethnic disparities in left ventricular diastolic function in a triethnic community cohort
The Medicare drug benefit (Part D) and treatment of heart failure in older adults
Fitness, fatness, and systolic blood pressure
LOWERing the INtensity of oral anticoaGulant Therapy in patients with bileaflet mechanical aortic valve replacement
Effectiveness of recanalization of chronic total occlusions
Remodeling is a more important determinant of lumen size than atheroma burden in left main coronary artery disease
Relative spatial distributions of coronary artery bypass graft insertion and acute thrombosis
Clopidogrel pretreatment in ST-elevation myocardial infarction patients transferred for percutaneous coronary Intervention
Correction
Correction
Correction
The dilemma of surgical or percutaneous approach in aortic stenosis
Cardiovascular disease risk profiles
Letter to the Editor Re
Letter to the Editor—Krishnaswamy response to Fiol